MGMT and metastatic malignant neoplasm in the lymph nodes: No significant differences were observed between the expression levels of MGMT and the selected clinicopathological characteristics, including patient staging, tumor location, tumor grade, tumor size, and lymph node metastasis (Table S2, Supporting Information).